Clinical outcomes of de novo metastatic her2-low breast cancer: a national cancer database analysis

HIGHLIGHTS

  • who: Changchuan Jiang from the (UNIVERSITY) have published the article: Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis, in the Journal: (JOURNAL) of December/31,/2017
  • what: This study examines and compares the clinical outcome of de novo metastatic HER2-low (IHC1+ or IHC2+/ISH-Negative) and HER2-zero (IHC 0) breast cancer using the NCDB, a national cancer outcome dataset in the United_States.
  • how: The results showed that HER2-low breast cancers had lower tumor grades and fewer visceral metastases. The results were partially consistent . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?